Navigation Links
Health Canada approves cold and flu medicine

Health Canada, the Canadian government regulatory agency, has approved wide-ranging new health claims for COLD-fX®, the most popular cold/flu remedy in Canada. After an extensive review, the Natural Health Products Directorate (NHPD) ?a division of Health Canada responsible for evaluating the safety, efficacy and quality of natural health products (NHPs) ?has issued COLD-fX with a much sought after license to sell to the public with specific science backed claims.

The comprehensive treatment claim for COLD-fX® approved by Health Canada states that the product “helps reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system.? Comprehensive therapeutic claims require support by the highest level of scientific evidence: randomized, double-blind, placebo-controlled clinical trials.

“This is our strongest point of medical recognition to date, and coming from the government authority whose responsibility it is to help Canadians maintain and improve their health, this approval should give great confidence to consumers,?said Dr. Jacqueline Shan, co-founder of CV Technologies, a University of Alberta spinoff company that developed COLD-fX.

Shan, who is also president, CEO and Chief Scientific Officer of CV Technologies added, “There are two novel therapeutic aspects to COLD-fX. First, COLD-fX is one of the very few medicines ?drugs or natural health products ?that Health Canada has approved for daily use as a preventative medicine. Second, COLD-fX can be taken to provide symptom relief for colds and flu."

Shan added that Health Canada reviewed all of CV Technologies published and unpublished data on COLD-fx before approving the claims.

The NHPD issues product licenses in several categories. Because COLD-fX® is a unique patented product, it was issued an NPN in the non-traditional category, which requires the highest level of scientific evidence. In contrast, claims with the term “tra ditional?are not based on scientific evidence and products in the "monograph" category have claims which are not supported by specific research on their particular product.

“There’s no cure for the common cold,?Dr. Shan stated. “So, in medicine the traditional strategy is if you can’t treat the disease, you treat the symptoms. The COLD-fX strategy is to boost your immune system to help you avoid getting a cold or the flu in the first place, or if you do get one, to fight it more effectively."

The NHPD’s safety review confirmed the safety profile of COLD-fX with no known side effects or drug interactions for generally healthy individuals.

Health Canada established new regulations effective Jan. 1, 2004, to monitor and manage the NHP industry. CV Technologies was the first company in Canada to launch and complete a trial under the new regulations. These regulations are being phased in over a six-year period as the NHPD reviews supporting safety, efficacy and quality information for all natural health products.

Although there are grey areas between the definitions of drugs and natural health products in general, the major distinction is that natural health products are derived from natural sources. Natural health products require the same degree of scientific evidence as drugs to support their claims. Natural health product regulations are also similar to drug regulations with requirements for standardized labeling, good manufacturing practices, and specification requirements for finished products and post-market surveillance for potential adverse effects.


Source:University of Alberta

Related biology news :

1. BioMed Central welcomes the new National Institutes of Health public access policy
2. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
3. Health costs soar as 60 million Americans classed as obese
4. Going To Extremes To Improve Human Health
5. Patient-choice C-section rate rises 36%: HealthGrades study
6. Grand Challenges in Global Health initiative funds Yale project
7. Health benefits of a Christmas brandy
8. Health of coral reefs detected from orbit
9. Health of Acehnese reefs in the wake of the tsunami shows human impacts more harmful
10. Healthy coral reefs of Madagascar resisting damage from climate change
11. Mailman School of Public Health researchers report blood DNA can be early predictor of liver cancer
Post Your Comments:

(Date:6/22/2016)... , June 22, 2016   ... management and verification solutions, has partnered with ... software solutions for Visitor Management, Self-Service Kiosks ... provides products that add functional enhancements to ... provides corporations and venues with an automated ...
(Date:6/20/2016)... DALLAS , June 20, 2016 ... criminal justice technology solutions for public safety, investigation, ... by the prisons involved, it has secured the ... Corrections (DOC) facilities for Managed Access Systems (MAS) ... (4) additional facilities to be installed by October, ...
(Date:6/9/2016)... 9, 2016  Perkotek an innovation leader in attendance control systems is proud to ... hours, for employers to make sure the right employees are actually signing in, and ... ... ... ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... 23, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... Laboratory, has joined STACS DNA as a Field Application Specialist. , “I am ... and COO of STACS DNA. “In further expanding our capacity as a scientific integrator, ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
Breaking Biology Technology: